Abstract
African swine fever (ASF) is a hemorrhagic and often fatal disease occurring in domestic pigs and wild boars. ASF can potentially greatly impact the global trade of pigs and pork products and threaten global food security. Outbreaks of ASF must be notified to the World Organization for Animal Health. In this study, we analyzed the feasibility of applying propidium monoazide (PMA) pretreatment-based infectious virus detection technology to ASF prevention and control and investigated the prospects of applying this technology for epidemic monitoring, disinfection effect evaluation, and drug development. PMA as a nucleic acid dye can enter damaged cells and undergo irreversible covalent crosslinking with nucleic acid under halogen light to prevent its amplification. Although this technology has been widely used for the rapid detection of viable bacteria, its application in viruses is rare. Therefore, we analyzed the theoretical feasibility of applying this technology to the African swine fever virus (ASFV) in terms of gene and cell composition. Rapid infectious ASFV detection technology based on PMA pretreatment would greatly enhance all aspects of ASF prevention and control, such as epidemic monitoring, disinfection treatment, and drug development. The introduction of this technology will also greatly improve the ability to prevent and control ASF.
The Challenge of African Swine Fever Detection
African Swine Fever (ASF) remains one of the most significant threats to the global swine industry. With mortality rates reaching 100% and no effective vaccine currently available, control strategies are limited to strict biosecurity, rapid detection, and the culling of infected herds.
A major bottleneck in current management is the limitation of standard molecular diagnostic tools like PCR. While highly sensitive, PCR cannot distinguish between infectious "live" viruses and non-infectious "dead" viral debris. This leads to several critical issues:
- False Positives: Environmental DNA from inactivated viruses can trigger unnecessary and costly culling operations.
- Ineffective Disinfection Assessment: PCR cannot quickly verify if disinfection protocols have successfully neutralized the virus.
- Slow Confirmation: The gold standard for confirming infectivity—virus isolation—is slow, labor-intensive, and requires high-containment (BSL-3) facilities.
The PMA Solution: Selective "Live" Detection
To address these challenges, researchers are exploring the use of Propidium Monoazide (PMA) as a pretreatment step in molecular workflows. PMA is a photoreactive dye that acts as a molecular filter, effectively "masking" DNA from damaged viruses so it isn't detected during amplification.
The mechanism relies on two key properties:
- Selective Entry: PMA is excluded by the intact membranes of infectious viruses but can penetrate the compromised membranes of inactivated or "dead" viruses.
- Photo-activation: Once inside a damaged virus, PMA intercalates into the DNA. Exposure to intense visible light causes the dye to covalently bind to the DNA, forming a complex that physically blocks PCR enzymes from amplifying that specific sequence.
Application to ASFV Management
Integrating PMA into ASFV detection workflows offers a rapid alternative to traditional cell culture methods. By combining PMA pretreatment with rapid amplification techniques like LAMP or RPA, field-deployable kits could provide biologically relevant results in hours rather than days.
Structural Feasibility
ASFV is a complex, multi-layered virus consisting of an envelope, capsid, inner membrane, and core shell. This intricate structure makes it an ideal candidate for PMA technology. The multiple layers provide a robust barrier for infectious particles while offering clear targets for damage during inactivation (e.g., by heat or chemical disinfectants), allowing PMA to enter and bind the viral genome.
Strategic Advantages
- Epidemic Monitoring: Provides a more accurate assessment of "infectious pressure" in the environment.
- Disinfection Evaluation: Allows for near real-time verification of cleaning protocols on farms and in transport vehicles.
- Drug Development: Enables researchers to monitor the survival trends of the virus during antiviral trials with higher throughput than pathological observations.
Limitations and Future Outlook
While the theoretical foundation is strong, practical implementation requires further optimization. The "recipe" for PMA treatment—including dye concentration (typically 50–150 µM for viruses), light intensity, and incubation times—must be tailored to specific ASFV strains and complex sample matrices like blood, feces, or soil. Furthermore, PMA primarily detects membrane damage; viruses inactivated by methods that leave the membrane intact (like certain UV treatments) may still yield false positives.
Despite these hurdles, PMA-based technology represents a necessary evolution in ASF management, bridging the gap between molecular speed and biological relevance.
Summary updated